+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Breast Lesion Localization Market Size, Share and Growth Outlook, 2026: Analysis By Localization Type (Wire Guided Localization, Radioisotope Localization, Magnetic Localization, Electromagnetic ), By Clinical Usage (Breast Biopsy Guidance, Breast Conservation Surgeries, Sentinel Lymph Node Identification), By Lesion Palpability (Non-Palpable Lesions, Palpable Lesions), By Product Category (Localization Devices , Identification Probes and Handheld Scanners, Software, Marking Kits, and Accessories), By End-User (Hospitals and Surgical Suites, Diagnostic Imaging and Radiology Centers, Specialty Breast Clinics, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Breast Lesion Localization Market size is forecast to increase from $2.79 Billion in 2026 to $5.01 Billion in 2034 at a CAGR of 7.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006097
Pages: 226 Pages

Breast Lesion Guidance Systems Market Size, Share and Growth Outlook, 2026: Analysis By Technology Type (Wire-Guided Localization , Magnetic Tracers and Seed Systems, Radioisotope , Electromagnetic Reflectors and Radar Systems, Radiofrequency Identification ), By Modality Compatibility (Ultrasound-Guided Systems, Mammography , MRI-Guided Systems, CT-Guided Systems), By Product Component (Core Guidance , Detection and Reader Systems, Accessories and Consumables), By End-User (Hospitals and Surgical Centers, Specialized Oncology and Breast Clinics, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Breast Lesion Guidance Systems Market size is forecast to increase from $1064.67 Million in 2026 to $2168.58 Million in 2034 at a CAGR of 9.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006096
Pages: 228 Pages

Breast Implants Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Silicone Implants, Saline Implants), By Shape (Round, Anatomical), By Texture (Smooth, Textured), By Application (Breast Augmentation, Breast Reconstruction), By End-User (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Breast Implants Market size is forecast to increase from $3.19 Billion in 2026 to $5.83 Billion in 2034 at a CAGR of 7.82% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006095
Pages: 223 Pages

Breast Imaging Market Size, Share and Growth Outlook, 2026: Analysis By Imaging Technique (Mammography, Breast Ultrasound, Breast MRI, Image-Guided Breast Biopsy, Molecular Breast Imaging), By Technology (Ionizing Technology, Non-Ionizing Technology), By Stage of Care (Screening, Diagnostic, Interventional), By End-User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Breast Care Centers) Companies, and Country Forecast, 2021 to 2034

Global Breast Imaging Market size is forecast to increase from $5.22 Billion in 2026 to $10.33 Billion in 2034 at a CAGR of 8.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006094
Pages: 230 Pages

Breast Conserving Surgery Market Size, Share and Growth Outlook, 2026: Analysis By Procedure Type (Lumpectomy , Partial Mastectomy, Quadrantectomy, Oncoplastic Breast Surgery ), By Product & Technology (Breast Conserving Surgical Instruments, Tissue Markers & Localization Devices , Surgical Imaging & Navigation Systems, Electrosurgical & Ablation Devices), By Application (Early-Stage Breast Cancer , Locally Advanced Breast Cancer , Benign Lesion Removal), By End-User (Hospitals, Specialty Oncology Centers, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Breast Conserving Surgery Market size is forecast to increase from $3.04 Billion in 2026 to $5.35 Billion in 2034 at a CAGR of 7.33% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006093
Pages: 223 Pages

Breast Cancer Monoclonal Antibodies Market Size, Share and Growth Outlook, 2026: Analysis By Product (Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies), By Treatment (Targeted Therapy, Biologic Therapy, Chemotherapy, Hormone Therapy, Surgery & Radiation Therapy), By End-User (Hospitals, Retail Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Breast Cancer Monoclonal Antibodies Market size is forecast to increase from $24.19 Billion in 2026 to $89.09 Billion in 2034 at a CAGR of 17.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006092
Pages: 220 Pages

Breast Cancer Liquid Biopsy Market Size, Share and Growth Outlook, 2026: Analysis By Circulating Biomarker (Circulating Tumor DNA , Circulating Tumor Cells , Extracellular Vesicles , Circulating RNA ), By Product & Service (Assay Kits & Reagents, Instruments & Platforms , Testing & Laboratory Services), By Clinical Application (Early Detection & Screening, Treatment Selection & Companion Diagnostics, Minimal Residual Disease , Treatment Response & Resistance Tracking), By End-User (Reference & Independent Diagnostic Laboratories, Hospitals & Cancer Institutes, Biopharmaceutical & Biotechnology Companies, Academic & Research Centers) Companies, and Country Forecast, 2021 to 2034

Global Breast Cancer Liquid Biopsy Market size is forecast to increase from $1.41 Billion in 2026 to $2.77 Billion in 2034 at a CAGR of 8.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006091
Pages: 215 Pages

Breast Cancer Imaging Market Size, Share and Growth Outlook, 2026: Analysis By Technology Type (Ionizing Breast Imaging , Non-ionizing Breast Imaging ), By Application (Screening & Early Detection, Diagnostic Imaging, Interventional & Image-Guided Biopsy), By End-User (Hospitals, Diagnostic Imaging Centers, Specialty Clinics & Breast Centers, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Breast Cancer Imaging Market size is forecast to increase from $4.23 Billion in 2026 to $8.24 Billion in 2034 at a CAGR of 8.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006090
Pages: 227 Pages

Breast Cancer Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Targeted Therapy , Hormonal Therapy , Chemotherapy , Immunotherapy ), By Cancer Type (Hormone Receptor-Positive , HER2-Positive Breast Cancer, Triple-Negative Breast Cancer ), By Stage of Disease (Early-Stage Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online) Companies, and Country Forecast, 2021 to 2034

Global Breast Cancer Drugs Market size is forecast to increase from $42.19 Billion in 2026 to $73.58 Billion in 2034 at a CAGR of 7.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006089
Pages: 223 Pages

Breast Cancer Diagnostics Market Size, Share and Growth Outlook, 2026: Analysis By Type of Test (Imaging Diagnostics, Biopsy and Histopathology Testing, Genomic and Molecular Assay Tests, Blood-Based Biomarker and Liquid Biopsy Tests), By Cancer Type (Ductal Carcinoma in Situ , Invasive Ductal Carcinoma , Invasive Lobular Carcinoma , Triple-Negative Breast Cancer ), By Application (Screening and Early Detection, Diagnostic Confirmation, Staging and Treatment Selection, Monitoring and Recurrence Surveillance), By End-User (Hospitals and Comprehensive Cancer Centers, Independent Diagnostic and Radiology Centers, Ambulatory Care Centers, Academic and Clinical Research Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Breast Cancer Diagnostics Market size is forecast to increase from $7.36 Billion in 2026 to $14.03 Billion in 2034 at a CAGR of 8.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006088
Pages: 224 Pages